arrow
P

Pauline Hamon

Tisch Cancer Institute
H指数:20
被引数:4,832

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dendritic cells control tertiary lymphoid structure development and maintenance in cancer

树突状细胞调控肿瘤中三级淋巴样结构的发育与维持

Science
IF45.8
2026-07-160
PRE
Humoral IgG1 responses to tumor antigens underpin clinical outcomes in immune checkpoint blockade

对肿瘤抗原的体液IgG1反应是免疫检查点阻断的临床结果的基础

2026-01-270
OAAI
Antimicrobial peptide delivery to lung as peptibody mRNA in anti-inflammatory lipids treats multidrug-resistant bacterial pneumonia

抗菌肽作为肽抗体mRNA,通过抗炎脂质递送至肺部,可治疗多药耐药细菌性肺炎

2025-11-260
PRE
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours

髓系祖细胞失调促进肿瘤中的免疫抑制性巨噬细胞

Nature
IF48.5
2025-09-100
PRE
Multiparametric cellular and spatial organization in cancer tissue lesions with a streamlined pipeline

癌症组织病变中的多参数细胞和空间组织及其简化流程

2025-08-250
OAAI
Hematopoietic aging promotes cancer by fueling IL-1⍺–driven emergency myelopoiesis

造血衰老通过促进IL-1驱动的紧急骨髓生成而促进癌症

Science
IF45.8
2024-01-010
OA
An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis
Nature
IF48.5
2023-12-060
PRE
Circulating senescent myeloid cells infiltrate the brain and cause neurodegeneration in histiocytic disorders
IMMUNITY
IF26.3
2023-12-0111
OAAI
Intratumoral dendritic cell-CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma

肝癌PD-1阻断后,肿瘤内树突状cell-CD4 T辅助细胞壁ni使CD8 T细胞分化

2023-06-15107
PRE
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer

TREM2巨噬细胞驱动肺癌中NK细胞的缺乏和功能障碍

2023-04-2066
PRE
Circulating tumor DNA (ctDNA) correlates closely with tumor necrosis and relapsefree survival (RFS) in hepatocellular carcinoma (HCC) patients treated with perioperative cemiplimab
2023-04-040
PRE
NEOADJUVANT NIVOLUMAB COMBINED WITH CCR2/5 INHIBITOR OR ANTI-IL-8 ANTIBODY IN NON-SMALL CELL LUNG CANCER AND HEPATOCELLULAR CARCINOMA
2022-11-072
OA
The interaction of CD4+ helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response

CD4辅助性T细胞与树突状细胞的相互作用塑造肿瘤微环境和免疫检查点阻断反应

2022-03-03113
PRE
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial

cemiplimab新辅助治疗可切除肝细胞癌: 一项单臂、开放标签、2期试验

2022-03-01121
OAAI